XYL Q1 2026 Earnings EPS Beat Drives Modest Stock Uptick Marker Therapeutics Q1 2026 Earnings NarrowerthanExpected Loss as Clinical Pipeline Progresses BCML Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency BellRing Brands BRBR Q1 2026 Earnings EPS Miss of 565 Triggers Slight Stock Decline Sonida Senior Living SNDA Q1 2026 Earnings EPS Misses Estimates by 555 Amid Operational Challenges COYA Q1 2026 Earnings NarrowerthanExpected Loss as Biotech Advances Pipeline